Cargando…

TLR signaling inhibitor, phenylmethimazole, in combination with tamoxifen inhibits human breast cancer cell viability and migration

Heightened co-expression and dysregulated signaling associated with Toll-like receptor 3 (TLR3) and Wnt5a is an integral component of solid tumors and hematological malignancies. Our previous findings in pancreatic cancer and melanoma suggest that inhibition of these pathways by a TLR3 signaling inh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwartz, Anthony L., Dickerson, Eric, Dagia, Nilesh, Malgor, Ramiro, McCall, Kelly D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768328/ https://www.ncbi.nlm.nih.gov/pubmed/29371911 http://dx.doi.org/10.18632/oncotarget.10358

Ejemplares similares

Phenylmethimazole Suppresses dsRNA-Induced Cytotoxicity and Inflammatory Cytokines in Murine Pancreatic Beta Cells and Blocks Viral Acceleration of Type 1 Diabetes in NOD Mice
por: McCall, Kelly D., et al.
Publicado: (2013)

Phenylmethimazole Blocks dsRNA-Induced IRF3 Nuclear Translocation and Homodimerization
por: Courreges, Maria C., et al.
Publicado: (2012)

Phenylmethimazole abrogates diet-induced inflammation, glucose intolerance and NAFLD
por: Patton, Ashley, et al.
Publicado: (2018)

Wnt5a, TLR2 and TLR4 are elevated in advanced human atherosclerotic lesions
por: Malgor, Ramiro, et al.
Publicado: (2013)

Diet Is Critical for Prolonged Glycemic Control after Short-Term Insulin Treatment in High-Fat Diet-Induced Type 2 Diabetic Male Mice
por: Guo, Aili, et al.
Publicado: (2015)

Consequences of Both Coxsackievirus B4 and Type 1 Diabetes on Female Non-Obese Diabetic Mouse Kidneys
por: Walter, Debra L., et al.
Publicado: (2021)

Phenylmethimazole is a candidate drug for the treatment of severe forms of coronavirus disease 2019 (COVID-19) as well as other virus-induced “cytokines storm”
por: Giuliani, Cesidio, et al.
Publicado: (2021)

Increased Wnt5a mRNA Expression in Advanced Atherosclerotic Lesions, and Oxidized LDL Treated Human Monocyte-Derived Macrophages
por: Bhatt, Pooja M., et al.
Publicado: (2012)

Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases
por: Ackers, Ian, et al.
Publicado: (2017)

Long-term evaluation of viability of microfilariae and intravenously transplanted adult Dirofilaria immitis in microfilaremic dogs treated with low-dose, short- and long-treatment regimens of doxycycline and ivermectin
por: McCall, John Wilson, et al.
Publicado: (2023)

Tamoxifen Rechallenge Decreases Metastatic Potential but Increases Cell Viability and Clonogenicity in a Tamoxifen-Mediated Cytotoxicity-Resistant Subline of Human Breast MCF7 Cancer Cells
por: Chang, Yung-Chieh, et al.
Publicado: (2020)

Precautions for Patients Taking Tamoxifen or Aromatase Inhibitors
por: Heery, Mary
Publicado: (2023)

SLC-0111, an inhibitor of carbonic anhydrase IX, attenuates hepatoblastoma cell viability and migration
por: Eloranta, Katja, et al.
Publicado: (2023)

Combination Treatment of Tamoxifen with Risperidone in Breast Cancer
por: Yeh, Wei-Lan, et al.
Publicado: (2014)

Cutaneous sarcoidosis possibly associated with aromatase inhibitors and tamoxifen
por: Sawada, Tomoya, et al.
Publicado: (2023)

The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors
por: Hussaarts, Koen G. A. M., et al.
Publicado: (2019)

Effects of Combined Pentadecanoic Acid and Tamoxifen Treatment on Tamoxifen Resistance in MCF−7/SC Breast Cancer Cells
por: To, Ngoc Bao, et al.
Publicado: (2022)

The Exposure of Breast Cancer Cells to Fulvestrant and Tamoxifen Modulates Cell Migration Differently
por: Lymperatou, Dionysia, et al.
Publicado: (2013)

Oxidized Low-Density Lipoprotein Induces WNT5A Signaling Activation in THP-1 Derived Macrophages and a Human Aortic Vascular Smooth Muscle Cell Line
por: Ackers, Ian, et al.
Publicado: (2020)

Tamoxifen to treat male pubertal gynaecomastia
por: Zehetner, Anthony
Publicado: (2015)

SUN-095 Attenuation of Inflammation by a Novel Small Molecule Prevents High Fat Diet-Induced Nonalcoholic Fatty Liver Disease
por: Patton, Ashley, et al.
Publicado: (2019)

Effectiveness of aromatase inhibitors and tamoxifen in reducing subsequent breast cancer
por: Haque, Reina, et al.
Publicado: (2012)

Priming BCL-2 to kill: the combination therapy of tamoxifen and ABT-199 in ER(+) breast cancer
por: Deng, Jing, et al.
Publicado: (2013)

AB081. Effects of combination therapy of Tamoxifen, L-carnitine and daily PDE5 inhibitors in the Peyronie’s disease
por: Kang, Jae Il, et al.
Publicado: (2016)

Efficacy of a novel topical combination of esafoxolaner, eprinomectin and praziquantel for the prevention of heartworm disease in cats
por: Baker, Christine, et al.
Publicado: (2021)

Dynamic biochemical tissue analysis detects functional selectin ligands on human cancer tissues
por: Martin, Eric W., et al.
Publicado: (2019)

IARC on tamoxifen.
Publicado: (1996)

Tamoxifen evolution
por: Howell, A., et al.
Publicado: (2023)

Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression
por: Raha, Paromita, et al.
Publicado: (2015)

Response of Mouse Breast Cancer Cells to Anastrozole, Tamoxifen, and the Combination
por: Xanthopoulos, J. M., et al.
Publicado: (2005)

Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast Cancer
por: Zboril, Emily K., et al.
Publicado: (2023)

Combined Inhibition of Autophagy and Caspases Fails to Prevent Developmental Nurse Cell Death in the Drosophila melanogaster Ovary
por: Peterson, Jeanne S., et al.
Publicado: (2013)

Uniaxial and Coaxial Nanofibers PCL/Alginate or PCL/Gelatine Transport and Release Tamoxifen and Curcumin Affecting the Viability of MCF7 Cell Line
por: Suárez, Diego Fernando, et al.
Publicado: (2022)

Effectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivo
por: Martin, Lesley-Ann, et al.
Publicado: (2012)

The tamoxifen-regulated, long non-coding RNA LINC00992 affects proliferation, migration, and expression of tamoxifen resistance-associated genes in MCF-7 breast cancer cells
por: Graf, Sebastian, et al.
Publicado: (2022)

Effects of local anesthetics on breast cancer cell viability and migration
por: Li, Ru, et al.
Publicado: (2018)

Differential Effects of Coating Materials on Viability and Migration of Schwann Cells
por: Klein, Silvan, et al.
Publicado: (2016)

Combination of Cyclopamine and Tamoxifen Promotes Survival and Migration of MCF-7 Breast Cancer Cells – Interaction of Hedgehog-Gli and Estrogen Receptor Signaling Pathways
por: Sabol, Maja, et al.
Publicado: (2014)

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine
por: Wang, Yuntao, et al.
Publicado: (2021)

Effects of Astaxanthin on the Proliferation and Migration of Breast Cancer Cells In Vitro
por: McCall, Buckley, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r6epgcem7da61n0gbgffp8p8e6